Episode Details

Back to Episodes
AI Found 21 New Genetic Clues to Glaucoma — Could Some Become Future Drug Targets?

AI Found 21 New Genetic Clues to Glaucoma — Could Some Become Future Drug Targets?

Published 1 month, 3 weeks ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/ai-found-21-new-genetic-clues-to-glaucoma-could-some-become-future-drug-targets

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

AI Found 21 New Genetic Clues to Glaucoma — Could Some Become Future Drug Targets? A study published in npj Genomic Medicine on September 19, 2026 used artificial intelligence to look for glaucoma-related patterns in optical coherence tomography scans, then tested those patterns against genetic data. The researchers reported 21 genetic loci not previously linked to glaucoma, and prioritized 11 genes that might help explain why glaucoma damages the eye. Five of those genes had not previously been reported in glaucoma research. () The work’s main advance is not that artificial intelligence diagnosed glaucoma better. It is that the researchers used measurable patterns of retinal damage—rather than a simple “glaucoma” or “no glaucoma” label—to search for genetic clues. That approach produced a richer biological picture, including a particularly promising signal involving RSPO2 and Wnt signaling in cells that help drain fluid from the eye. But these are genetic leads, not tested glaucoma treatments. The study did not show that changing any of the 11 genes prevents vision loss. The most exciting possibilities still require experiments to establish which genes are truly involved, whether changing them would help or harm, and whether a treatment can reach the right cells safely. What the study found—and what it did not The peer-reviewed article is “Deep-learning-derived glaucoma-related endophenotypes enable novel genome-wide genetic and functional discovery”. It reports 36 genome-wide significant loci in the European-ancestry analysis and 43 in a cross-ancestry analysis. The authors identified 21 loci as previously unreported in glaucoma and used additional analyses to prioritize 11 genes, five of them novel to glaucoma. () A locus is a region of the genome associated with a trait; it may contain several genes. A gene prioritized at a locus is a candidate for explaining the association, not necessarily the gene that causes it. The study therefore offers a set of hypotheses about glaucoma biology. It does not establish that the 21 loci—or any of the 11 genes—cause glaucoma, nor that a drug aimed at them would work. The methodological innovation, in patient-friendly language From a yes-or-no label to a detailed retinal “fingerprint” Many genetic studies classify each participant as having glaucoma or not having glaucoma. That can be a noisy comparison: some people may have undiagnosed disease, and people with glaucoma can have very different patterns and amounts of retinal damage. Instead, these researchers trained machine-learning models on eye scans from people with glaucoma. The models learned patterns in the ganglion cell complex and retinal nerve fiber layer—retinal structures that are affected as glaucoma damages the optic nerve. They then represented those patterns as quantitative traits, or measurable features of the scans. A useful analogy is the difference between asking whether a house is “damaged” and measuring exactly where its walls are cracked, how deep the cracks are, and how much the structure has shifted. The detailed measurements can reveal more about the process behind the damage. These scan-derived traits, which the researchers call endophenotypes, were then linked to genetic differences. They are glaucoma-informed measurements, not a replacement diagnosis or a measure of future visio

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us